Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quyu Jiedu Granule is a compound traditional Chinese herbal medicine formulated for the purpose of "removing blood stasis and expelling superficial evils" according to traditional Chinese medicine (TCM) theory. It has been studied primarily in the context of endometriosis and infertility, where it appears to improve the microenvironment of ova by reducing inflammatory cytokines such as tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6), potentially improving oocyte quality in patients with endometriosis undergoing IVF-ET[1][2]. The formula is also referenced as a maintenance therapy for metastatic colorectal cancer in clinical trial settings[7]. Its mechanism is believed to involve immunomodulation and anti-inflammatory effects through downregulation of pro-inflammatory cytokines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Quyu Jiedu Granule.